{
  "docId": "019dd923-622c-750b-8b99-9ee2a1e788fb",
  "docSlug": "1233d0b05ad9",
  "documentTitle": "PROCEPT BioRobotics Corporation (PRCT)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-16 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 44,
  "pageCount": 100,
  "prevPage": 43,
  "nextPage": 45,
  "slideType": "testimonial",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a table format to present qualitative evidence (interviews) to support a bearish thesis.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "data_table",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-9ee2a1e788fb/44",
  "deckHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb#slide-44",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.96,
        "x": 0.02,
        "y": 0.91
      },
      "kind": "callout",
      "text": "Current users seem to be expecting significant price concessions from Procept if they choose to upgrade to HYDROS.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4de7de79-6ae4-44ab-aa60-d4965d5e6251",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "Based on our conversations with former Procept sales reps and current AquaBeam users, we believe the modest improvements offered by HYDROS are unlikely to drive material incremental conversion. As important, we heard high levels of price sensitivity, suggesting existing users are expecting substantial discounts in order to upgrade.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ca788f8-df8e-4f1f-9b41-bd723122aa18",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "…it’s not as if [HYDROS] is adding to the TAM that already exists for the robot… — Former Procept Executive, Nov 2024; if you’re somebody that’s doing three a month or a hospital system that’s doing only five a month, there’s no rush to go get that new system. Absolutely not. — Former Procept Sales Rep, Nov 2024; Now, if they are a low volume customer, probably they won’t [upgrade to HYDROS], but if they’re, I would say medium to high, I would say they will upgrade. — Former Procept Manager, Nov 2024; …I believe they are offering sort of discounts and other things like that for hospitals that want to upgrade, and I don’t know how many are taking advantage of it. I would guess that they’re offering trade in trade up programs… — Former Procept Executive, Nov 2024; Now here’s where it gets a little awkward. I don’t know if this is good or bad, but I said to them, so when do you give me my HYDROS? And they said, ‘…I think we could do a trade-in for $450,000’, and I said, ‘I don’t think so. It’s got to be a freebie because… there’s no way I could get my hospital paid $450,000 just so I don’t have to turn my head left to right. I think there’s going to be a little weirdness…I think they got to give [HYDROS] for free or they’re going to piss people off…If [my hospital] were to say to me, ‘dude, do we really need to upgrade? Is it better?’ I would say, ‘no, not at all.’” — Major Hospital Urologist, Nov 2024",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-ee35-7258-b4da-efdd528b514b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.02,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Spruce Point research",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1bc57d34-cee7-4ee8-8a83-96d217b93898",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.62,
        "w": 0.96,
        "x": 0.02,
        "y": 0.27
      },
      "kind": "table",
      "text": "Former Sales Rep and Urologist Views on the New HYDROS System",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8034f88-cfa0-414e-8308-e77554790050",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.68,
        "x": 0.28,
        "y": 0.03
      },
      "kind": "title",
      "text": "We Believe Procept's HYDROS System Is Unlikely To Spur Incremental Adoption And We See Pricing Pressures",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53b8b0ea-74c9-49a6-817a-478b8fedaaa9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "57b1d0c2-104b-43a7-8208-dee59f25b119",
      "evidence": "Uses interviews with former employees and industry experts to validate the thesis.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}